HUENENBERG, Switzerland - Alcon announced today that it now has received all required regulatory clearances related to its tender offer for WaveLight AG. With all closing conditions now satisfied, Alcon has commenced with the closing of the offer and directed its agent, Deutsche Bank AG, to proceed with cash settlement for tendered shares. Upon settlement of the tendered shares, Alcon will own 77.4 percent of the outstanding shares of WaveLight. 

Shareholders who tendered their shares under the offer will automatically receive payment against their tendered shares in accordance with the terms of the offer.

About Alcon (NYSE: ACL)
Alcon, Inc. is the world's leading eye care company, with sales of approximately $4.9 billion in 2006. Alcon, which has been edicated to the ophthalmic industry for 60 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestlé, S.A., the world's largest food company.